Articles related to COLORECTAL CANCER (CRC)

Symptom overlap creates diagnostic challenges, but specific patterns like post-bowel movement pain relief in IBS versus weight loss and bloody stools in colon cancer guide clinical differentiation.

The increasing incidence of young-onset colorectal cancer, comprising more than 10% of diagnoses in patients under 50, signals the need for heightened clinical awareness and prompt evaluation of suspicious symptoms regardless of age.

In the BLUE-C trial, Cologuard Plus demonstrated a 93.9% sensitivity for colorectal cancer detection, significantly outperforming the 67.3% sensitivity of FIT.

Medical errors are now recognized as the third leading cause of death in the US, emphasizing the urgent need for improved safety measures in healthcare settings.

Recent findings suggest extending follow-up colonoscopy intervals to 15 years for patients without a family history of colorectal cancer and with initial negative results. This could reduce unnecessary procedures without significantly increasing cancer risk.

Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.